| Analysis | Metabolite Name | Measured Value | Units | Sex | Severity_Scale | Race | Ethnicity | hasSmokingBeforeCOVID-19 | Time |
|---|---|---|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.702633673 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.67399158 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.66818356 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.647905835 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.638854831 | log transformed data | Male | 2 | Other | Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.631180373 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.619152805 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.615661042 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.61002828 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.60758423 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.606490835 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.601887084 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.597369133 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.596869983 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.588975231 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.57548854 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.574947785 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.571097153 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.564916548 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.562204478 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.558061392 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.556488478 | log transformed data | Female | 2 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.546281468 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.534722477 | log transformed data | Female | 2 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.533135492 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.530466278 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.518791014 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.518723516 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.517424184 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.513454235 | log transformed data | Male | 1 | Black | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.512233237 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.50429255 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.5038376 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.502349129 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.490622123 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.487225444 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.48313103 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.480165512 | log transformed data | Male | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.473325788 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.473209461 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.472513802 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.469365763 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.467697835 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.467561069 | log transformed data | Female | 2 | Black | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.465625647 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.464499552 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.460484902 | log transformed data | Female | 2 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.459719695 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.444931055 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.444030411 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.437351054 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.435771365 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.433389027 | log transformed data | Male | 3 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.430327297 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.426538265 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.425676643 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.425131151 | log transformed data | Male | 3 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.422847719 | log transformed data | Female | 1 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.418139147 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.415713803 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.411926754 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.41060168 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.408976096 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.408931231 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.406751568 | log transformed data | Male | 0 | White | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.400634614 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.399810394 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.397430772 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.396850859 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.395410362 | log transformed data | Female | 0 | White | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.383379822 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.382439945 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.380037935 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.378953609 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.377576283 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.375846404 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.37449132 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.374098542 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.373767022 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.373508595 | log transformed data | Male | 1 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.373038456 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.372140234 | log transformed data | Female | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.371970003 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.371033364 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.368950369 | log transformed data | Male | 1 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.367869798 | log transformed data | Female | 1 | Black | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.367615445 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.366472622 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.36201302 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.360180225 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.355791796 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.351514616 | log transformed data | Male | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.34698625 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.346759239 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.344727695 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.337985513 | log transformed data | Female | 2 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.337352914 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.331892018 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.331756727 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.330403181 | log transformed data | Male | 1 | Other | Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.326602366 | log transformed data | Male | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.323320474 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.322550416 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.321273607 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.320601231 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.319798603 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.316631161 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.314209339 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.311888623 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.311498988 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.309630467 | log transformed data | Female | 2 | Other | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.30959405 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.308952175 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.308492967 | log transformed data | Female | 2 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.305869659 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.305375638 | log transformed data | Female | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.305203457 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.305166477 | log transformed data | Male | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.302331596 | log transformed data | Female | 1 | White | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.30193888 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.301153133 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.29938499 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.297263008 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.296282177 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.291899787 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.291374853 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.291189981 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.29051042 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.290166804 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.288423393 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.285241914 | log transformed data | Male | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.28315019 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.279448764 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.279175782 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.277713232 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.27625237 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.275951788 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.274479419 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.274102085 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.273907194 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.270454554 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.269850334 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.268970889 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.265607307 | log transformed data | Female | 0 | Other | Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.263809266 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.2600623 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.259509882 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.259090952 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.258967429 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.258916362 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.256867723 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.256140659 | log transformed data | Male | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.256102576 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.25453897 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.254335684 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.253655466 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.252613151 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.251812347 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.249453184 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.248613624 | log transformed data | Male | 2 | Other | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.248598629 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.248334341 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.247892054 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.246261612 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.24589915 | log transformed data | Female | 1 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.243942235 | log transformed data | Male | 3 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.243637134 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.24166466 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.240753741 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.236228735 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.234623957 | log transformed data | Male | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.233892273 | log transformed data | Female | 2 | White | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.233122282 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.230524497 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.22912196 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.227928181 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.227789136 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.227673651 | log transformed data | Male | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.224645059 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.224630146 | log transformed data | Female | 0 | White | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.224115285 | log transformed data | Female | 3 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.222126051 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.221868984 | log transformed data | Female | 2 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.220142171 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.219697143 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.218395348 | log transformed data | Male | 0 | Other | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.215941273 | log transformed data | Male | 0 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.212598447 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.211220195 | log transformed data | Female | 2 | Other | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.21014483 | log transformed data | Female | 2 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.209107254 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.208015338 | log transformed data | Male | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.207800081 | log transformed data | Male | 0 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.207397381 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.206297341 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.204193725 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.204132919 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.203904618 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.203200991 | log transformed data | Male | 0 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | laurylcarnitine (C12) | -0.202537426 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Return to search page
